Conatus Says Data Supports Moving Forward With Liver Disease DrugConatus Says Data Supports Moving Forward With Liver Disease Drug

Conatus Pharmaceuticals Inc said on Thursday initial results from small early stage trials supported continued development of its experimental drug for patients with cirrhosis and liver impairment. Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news